Letter to editor ‘prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with Rifaxamin’

doi:10.3748/wjg.v26.i44.7085

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 44

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6851)

All Articles published online

The chart showing PDF series, WORD series, HTML series.

Item

Count

PDF

462

WORD

180

HTML

2757

Sum=3399

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1130

Download

2323

Sum=3453

Nov 28, 2020 (publication date) through Feb 22, 2026

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Letter to the Editor

World J Gastroenterol. Nov 28, 2020; 26(44): 7085-7087
Published online Nov 28, 2020. doi: 10.3748/wjg.v26.i44.7085

Letter to editor ‘prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with Rifaxamin’

Amera Elzubeir, Syed Munawer Alam

Amera Elzubeir, Syed Munawer Alam, Department of Gastroenterology, Norfolk and Norwich University Hospital, Norwich NR46AY, Norfolk, United Kingdom

Author contributions: Both authors wrote and edited the manuscript

Conflict-of-interest statement: The authors declare they have no conflicts of interest.

Corresponding author: Syed Munawer Alam, FRCP, MBBS, Doctor, Department of Gastroenterology, Norfolk and Norwich University Hospital, Colney Lane Norwich Norfolk, Norwich NR46AY, Norfolk, United Kingdom. syed.alam@nnuh.nhs.uk

Received: June 25, 2020
Peer-review started: June 25, 2020
First decision: July 28, 2020
Revised: August 26, 2020
Accepted: November 9, 2020
Article in press: November 9, 2020
Published online: November 28, 2020
Processing time: 154 Days and 12.3 Hours

Abstract

The present letter to editor is related to Bohra A et al Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care. World J Gastroenterol 2020; 26(18): 2221-2231. Hepatic encephalopathy (HE) is a significant and frequent major decompensating event in cirrhosis. However clinical studies examining the clinical outcome of HE are lacking despite its high prevalence.

Keywords: Hepatic encephalopathy; Cirrhosis; Rifaxamin; Portal hypertension; Acute on chronic liver failure; Prognosis

Core Tip: This letter to editor serves to add to the ongoing conversation regarding hepatic encephalopathy (HE) and its prognostic significance. The major highlight of this letter is to stress the importance of recognizing other prognostically significant variables such as sarcopenia and active Hepatitis C, which may adversely impact the severity and outcomes of HE. Furthermore it serves to actively encourage future studies in this area.